ArticleStem cells translational medicine2026

Predicting metabolic dysfunction-associated steatotic liver disease risk using patient-derived induced pluripotent stem cells.

Yuanyuan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.